An unusual rhodium-catalyzed C–H activation/Lossen
rearrangement/oxa-Michael
addition tandem cyclization has been achieved along with a tunable
well-known C–H activation/[4 + 2] annulation, leading to regio-,
chemo-, and diastereoselective access to diverse pentacyclic α-carbolines
and β-carboline-1-one derivatives in moderate to good yields
with significant anticancer activity.